Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients

Quality of Life Clinical Trial

Official title:

Smoking Trajectory in Newly Diagnosis Lung Cancer Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03642041
• Other study ID #: TWNA-1042011
• Status: Completed
• Start date: May 24, 2014
• Est. completion date: July 30, 2018

Study information

• Verified date: August 2018
• Source: National Defense Medical Center, Taiwan
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

1. Understanding the smoking change patterns among the newly diagnosis lung cancer patients after cancer diagnosis.

2. Explore the related factors of the smoking change patterns.

3. The type of smoking trajectory impact on survival and quality of life.

Description:

This was a prospective longitudinal design study. The investigators used the structure questionnaires to collect the data from a consecutive sample of newly diagnosed lung cancer patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 406
• Est. completion date: July 30, 2018
• Est. primary completion date: July 22, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• Over 20 years old

• Newly diagnosed lung cancer

• Conscious clear and able to communicate

• Agreed to participate the study

Exclusion Criteria:

• Consciously confused

• Cognitive or psychotic disorders

Related Conditions & MeSH terms

• Lung Neoplasms
• Newly Diagnosed Lung Cancer
• Quality of Life
• Smoking, Cigarette
• Survival

Intervention

Behavioral:
• smoking
smoking behavior

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
National Defense Medical Center, Taiwan

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes From Baseline Smoking Behavior at 1,2,3,4,5,6 Months	Self-reported smoking during the last 30 days was a dichotomous variable.	baseline, 1-month, 2-month, 3-month, 4-month, 5-month, 6-month
Secondary	Changes From Baseline Quality of Life at 1,2,3,4,5,6 Months	Functional Assessment of Cancer Therapy-Lung, Version 4 (FACT-L v. 4) was a 36-item ordinal scale, five-point scale from 0 (not at all) to 4 (very much). There were 5 domains: Physical, social/family, emotional, and functional well-being; lung cancer subscale (symptoms, cognitive function, regret of smoking). Subscale scores added to obtain total score, with higher scores indicating better quality of life.	baseline, 1-month, 2-month, 3-month, 4-month, 5-month, 6-month
Secondary	Proportion of participants with Overall Survival up to 2 years	survival	follow up to one or two years